FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Nevill

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Cyclophosphamide

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Yasser R Abou Mourad; Michael J Barnett; Rahul Bhargava; Hélène Bruyère; Donna L Forrest; Tanya Gillian; Stephen H Nantel; Thomas J Nevill; Cynthia L Toze; John D Shepherd
Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals.
Cynthia L Toze; Sean S Young; Clayton A Smith; Kevin W Song; Heather J Sutherland; Yasser R Abou Mourad; Michael J Barnett; Raewyn C Broady; Joseph Michael Connors; Chinmay B Dalal; Donna L Forrest; Tanya L Gillan; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Adisak Tantiworawit; Cynthia L Toze; Yasser R Abou-Mourad; Michael J Barnett; Raewyn C Broady; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd; Kevin W Song; Heather J Sutherland; Donna L Forrest
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Nevill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yasser R Abou Mourad; Michael J Barnett; Rahul Bhargava; Hélène Bruyère; Donna L Forrest; Tanya Gillian; Stephen H Nantel; Thomas J Nevill; Cynthia L Toze; John D Shepherd
Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals.
Clinical lymphoma, myeloma & leukemia 2013;13(3):281-6.
2012: Cynthia L Toze; Sean S Young; Clayton A Smith; Kevin W Song; Heather J Sutherland; Yasser R Abou Mourad; Michael J Barnett; Raewyn C Broady; Joseph Michael Connors; Chinmay B Dalal; Donna L Forrest; Tanya L Gillan; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
British journal of haematology 2012;158(2):174-85.
2012: Adisak Tantiworawit; Cynthia L Toze; Yasser R Abou-Mourad; Michael J Barnett; Raewyn C Broady; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd; Kevin W Song; Heather J Sutherland; Donna L Forrest
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Leukemia & lymphoma 2012;53(7):1321-6.
2012: D Telio; L Zypchen; M Barnett; D Forrest; Thomas J Nevill; J Shepherd; Kevin W Song
High-dose melphalan followed by auto-SCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease.
Bone marrow transplantation 2012;47(3):453-5.
2010: Y R Abou-Mourad; B C Lau; Michael J Barnett; Donna L Forrest; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; John D Shepherd; C A Smith; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Julye C Lavoie
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
Bone marrow transplantation 2010;45(2):295-302.
2009: Thomas J Nevill; John D Shepherd; Heather J Sutherland; Yasser R Abou Mourad; Julye C Lavoie; Michael J Barnett; Stephen H Nantel; Cynthia L Toze; Donna E Hogge; Donna L Forrest; Kevin W Song; Maryse M Power; Janet Nitta; Yunfeng Dai; Clayton A Smith
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):205-13.
2009: Donna L Forrest; Shannon Trainor; Ryan R Brinkman; Michael J Barnett; Donna E Hogge; Thomas J Nevill; John D Shepherd; Stephen H Nantel; Cynthia L Toze; Heather J Sutherland; Kevin W Song; Julye C Lavoie; Maryse M Power; Yasser Abou-Mourad; Clayton A Smith
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
Leukemia research 2009;33(2):271-5.
2008: K M Ramadan; Joseph Michael Connors; A J Al-Tourah; Kevin W Song; Randy D Gascoyne; Michael J Barnett; Thomas J Nevill; John D Shepherd; Stephen H Nantel; Heather J Sutherland; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Y R Abou-Mourad; Mukesh Chhanabhai; Nicholas J Voss; Ryan R Brinkman; C A Smith; Cynthia L Toze
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.
Bone marrow transplantation 2008;42(9):601-8.
2007: John Kuruvilla; John D Shepherd; Heather J Sutherland; Thomas J Nevill; Janet Nitta; Alan Le; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Cynthia L Toze; Clayton A Smith; Michael J Barnett; Kevin W Song
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):925-31.
2007: T Y Halim; Kevin W Song; Michael J Barnett; Donna L Forrest; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Cynthia L Toze; Julye C Lavoie
Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1246-52.
2007: Kevin W Song; Michael J Barnett; Randy D Gascoyne; Mukesh Chhanabhai; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Cynthia L Toze; Nicholas J Voss; Joseph Michael Connors
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):535-40.
2006: Yulia Lin; Hélène Bruyère; Douglas E Horsman; Tapio Pantzar; Michael J Barnett; Donna E Hogge; Thomas J Nevill; Stephen H Nantel; Heather J Sutherland; Cynthia L Toze; John D Shepherd; Julye C Lavoie; Kevin W Song; Clayton A Smith; Donna L Forrest
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
Cancer genetics and cytogenetics 2006;170(1):16-23.
2006: M J Greenwood; Matthew D Seftel; C Richardson; D Barbaric; Michael J Barnett; Helene Bruyere; Donna L Forrest; Douglas E Horsman; C Smith; K Song; Heather J Sutherland; Cynthia L Toze; Thomas J Nevill; Stephen H Nantel; Donna E Hogge
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia.
Leukemia & lymphoma 2006;47(7):1245-52.
2006: Kevin W Song; Michael J Barnett; Randy D Gascoyne; Douglas E Horsman; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Nicholas J Voss; Cynthia L Toze; Joseph Michael Connors
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.
British journal of haematology 2006;133(6):634-7.
2006: Asha Johny; Kevin W Song; Stephen H Nantel; Julye C Lavoie; Cynthia L Toze; Donna E Hogge; Donna L Forrest; Heather J Sutherland; Alan Le; Janet Nitta; Michael J Barnett; Clayton A Smith; John D Shepherd; Thomas J Nevill
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):480-9.
2005: Donna L Forrest; Donna E Hogge; Thomas J Nevill; Stephen H Nantel; Michael J Barnett; John D Shepherd; Heather J Sutherland; Cynthia L Toze; Clayton A Smith; Julye C Lavoie; Kevin W Song; Nicholas J Voss; Randy D Gascoyne; Joseph Michael Connors
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7994-8002.
2005: Cynthia L Toze; A Galal; Michael J Barnett; John D Shepherd; Eibhlin Conneally; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; Heather J Sutherland; Joseph Michael Connors; Nicholas J Voss; Thomas L Kiss; Hans A Messner; Julye C Lavoie; Donna L Forrest; Kevin W Song; C A Smith; Jeff Lipton
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.
Bone marrow transplantation 2005;36(9):825-30.
2005: Richard T Doocey; Cynthia L Toze; Joseph Michael Connors; Thomas J Nevill; Randy D Gascoyne; Michael J Barnett; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Clayton A Smith; Kevin W Song
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
British journal of haematology 2005;131(2):223-30.
2005: Julye C Lavoie; Joseph Michael Connors; Gordon L Phillips; Donna Reece; Michael J Barnett; Donna L Forrest; Randy D Gascoyne; Donna E Hogge; Stephen H Nantel; John D Shepherd; Clayton A Smith; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Nicholas J Voss; Thomas J Nevill
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.
Blood 2005;106(4):1473-8.
2005: Kevin W Song; Peter Mollee; Donna E Hogge; Vikas Gupta; Michael J Barnett; Donna L Forrest; Julye C Lavoie; Thomas J Nevill; Stephen H Nantel; John D Shepherd; Clay A Smith; Heather J Sutherland; Cynthia L Toze; Michael Crump; Armand Keating
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Leukemia & lymphoma 2005;46(4):525-31.
2004: John Kuruvilla; Donna L Forrest; Julye C Lavoie; Stephen H Nantel; John D Shepherd; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Donna E Hogge; Thomas J Nevill
Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;34(11):969-73.
2004: Cynthia L Toze; Michael J Barnett; Joseph Michael Connors; Randy D Gascoyne; Nicholas J Voss; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Heather J Sutherland; Julye C Lavoie; Donna L Forrest; Kevin W Song; Donna E Hogge
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation.
British journal of haematology 2004;127(3):311-21.
2004: Haytham Khoury; Bakul I Dalal; Stephen H Nantel; Douglas E Horsman; Julye C Lavoie; John D Shepherd; Donna E Hogge; Cynthia L Toze; Kevin W Song; Donna L Forrest; Heather J Sutherland; Thomas J Nevill
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21).
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(10):1211-6.
2004: Chantal S Léger; Thomas J Nevill
Hematopoietic stem cell transplantation: a primer for the primary care physician.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(10):1569-77.
2003: Donna L Forrest; Thomas J Nevill; Sheldon C Naiman; Alan Le; DA Brockington; Michael J Barnett; Julye C Lavoie; Stephen H Nantel; Kevin W Song; John D Shepherd; Heather J Sutherland; Cynthia L Toze; J H Davis; Donna E Hogge
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Bone marrow transplantation 2003;32(9):915-23.
2003: Haytham Khoury; Bakul I Dalal; Thomas J Nevill; Douglas E Horsman; Michael J Barnett; John D Shepherd; Cynthia L Toze; Eibhlin Conneally; Heather J Sutherland; Donna E Hogge; Stephen H Nantel
Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
Leukemia & lymphoma 2003;44(10):1713-8.
2003: Andrew Daly; K Song; Thomas J Nevill; Stephen H Nantel; Cynthia L Toze; Donna E Hogge; D Forrest; J Lavoie; Heather J Sutherland; J Shepherd; Wanda S Hasegawa; Jeff Lipton; Hans A Messner; Thomas L Kiss
Stem cell transplantation for myelofibrosis: a report from two Canadian centers.
Bone marrow transplantation 2003;32(1):35-40.
2003: Haytham Khoury; C F Poh; M Williams; Julye C Lavoie; Thomas J Nevill
Acute myelogenous leukemia complicated by acute necrotizing ulcerative gingivitis due to Aspergillus terreus.
Leukemia & lymphoma 2003;44(4):709-13.
2002: Joel B Epstein; N Phillips; J Parry; Matthew S Epstein; Thomas J Nevill; Peter Stevenson-Moore
Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2002;30(11):785-92.
2002: Matthew D Seftel; Helene Bruyere; M Copland; Donna E Hogge; Douglas E Horsman; Stephen H Nantel; John D Shepherd; Julye C Lavoie; Alan Le; Heather J Sutherland; Cynthia L Toze; Thomas J Nevill
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
European journal of haematology 2002;69(4):193-9.
2002: Donna L Forrest; K Thompson; Thomas J Nevill; Stephen Couban; L A V Fernandez
Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma.
Bone marrow transplantation 2002;29(12):973-8.
2002: Yves Chalandon; Michael J Barnett; Douglas E Horsman; Eibhlin Conneally; Stephen H Nantel; Thomas J Nevill; Janet Nitta; John D Shepherd; Heather J Sutherland; Cynthia L Toze; Donna E Hogge
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(8):435-43.
2000: Donna L Forrest; Stephen Couban; Thomas J Nevill; C Y Lee; P J Welch
Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19): an indolent pathologic entity.
Cancer genetics and cytogenetics 2000;122(2):134-6.
2000: Kirk R Schultz; Thomas J Nevill; Robert Balshaw; Cynthia L Toze; Traci Corr; C J Currie; DK Strong; Paul Keown
Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Bone marrow transplantation 2000;26(5):545-51.
2000: C A Lohrisch; Thomas J Nevill; Michael J Barnett; Donna E Hogge; Joseph Michael Connors; Paul Keown; R D Gascoyne
Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma.
Leukemia & lymphoma 2000;39(1-2):195-201.
2000: Donna L Forrest; B J Mack; Thomas J Nevill; Stephen Couban; Ekram Zayed; Annette Foyle
Bone marrow necrosis in adult acute leukemia and non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;38(5-6):627-32.
2000: K G McCaul; Thomas J Nevill; Michael J Barnett; Cynthia L Toze; C J Currie; Heather J Sutherland; Eibhlin Conneally; John D Shepherd; Stephen H Nantel; Donna E Hogge; Hans G Klingemann
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.
Journal of hematotherapy & stem cell research 2000;9(3):367-74.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Michael J Barnett
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(6):605-12.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Eibhlin Conneally; Michael J Barnett
Allografting for indolent lymphoid neoplasms.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():59-61.
1999: Donna L Forrest; SA Adomat; Thomas J Nevill; M J Barnett; G Growe; Douglas E Horsman
Detection of MLL gene self-fusions by RT-PCR and automated fluorescent DNA-fragment analysis.
Cancer genetics and cytogenetics 1999;112(2):181-3.
1999: Donna Reece; Thomas J Nevill; A Sayegh; John Spinelli; DA Brockington; Michael J Barnett; Hans G Klingemann; Joseph Michael Connors; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Randall Fairey; Susan E O'Reilly; Gordon L Phillips
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease.
Bone marrow transplantation 1999;23(11):1131-8.
1998: Donna L Forrest; Thomas J Nevill; Douglas E Horsman; DA Brockington; Henry Fung; Cynthia L Toze; Eibhlin Conneally; Donna E Hogge; Heather J Sutherland; Stephen H Nantel; John D Shepherd; Michael J Barnett
Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities.
British journal of haematology 1998;103(3):630-8.
1998: I N Micallef; Mukesh Chhanabhai; Randy D Gascoyne; John D Shepherd; Henry Fung; Stephen H Nantel; Cynthia L Toze; Hans G Klingemann; Heather J Sutherland; Donna E Hogge; Thomas J Nevill; Alan Le; Michael J Barnett
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
Bone marrow transplantation 1998;22(10):981-7.
1998: Thomas J Nevill; Henry Fung; John D Shepherd; Douglas E Horsman; Stephen H Nantel; Hans G Klingemann; Donna L Forrest; Cynthia L Toze; Heather J Sutherland; Donna E Hogge; Sheldon C Naiman; Alan Le; DA Brockington; Michael J Barnett
Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.
Blood 1998;92(6):1910-7.
1998: Kirk R Schultz; Thomas J Nevill; Cynthia L Toze; Traci Corr; C Currie; DK Strong; Paul Keown
The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
Transplantation proceedings 1998;30(5):1668-70.
1998: D R Simpson; Thomas J Nevill; John D Shepherd; Henry Fung; Douglas E Horsman; Stephen H Nantel; Linda M Vickars; Heather J Sutherland; Cynthia L Toze; Donna E Hogge; Hans G Klingemann; Sheldon C Naiman; Michael J Barnett
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation.
Bone marrow transplantation 1998;22(3):259-64.
1997: L A V Fernandez; R Cheng; Irene Sadek; Thomas J Nevill; Judith MacSween
Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR).
Clinical and experimental immunology 1997;108(3):557-61.
1995: Gordon L Phillips; Thomas J Nevill; John Spinelli; Stephen H Nantel; Hans G Klingemann; Michael J Barnett; John D Shepherd; K W Chan; Jacinta Meharchand; Heather J Sutherland
Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation.
Bone marrow transplantation 1995;15(2):213-9.
1993: Michael J Barnett; C M Coppin; N Murray; Thomas J Nevill; Donna Reece; Hans G Klingemann; John D Shepherd; Stephen H Nantel; Heather J Sutherland; Gordon L Phillips
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
British journal of cancer 1993;68(3):594-8.
1992: Thomas J Nevill; John D Shepherd; Donna Reece; Michael J Barnett; Stephen H Nantel; Hans G Klingemann; Gordon L Phillips
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT.
Bone marrow transplantation 1992;10(5):445-50.
1992: Thomas J Nevill; M H Tirgan; H J Deeg; Hans G Klingemann; Donna Reece; John D Shepherd; Michael J Barnett; Gordon L Phillips
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.
Bone marrow transplantation 1992;9(5):349-54.
1991: Gordon L Phillips; John D Shepherd; Michael J Barnett; P M Lansdorp; Hans G Klingemann; John Spinelli; Thomas J Nevill; K W Chan; Donna Reece
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1880-8.
1991: Thomas J Nevill; Michael J Barnett; Hans G Klingemann; Donna Reece; John D Shepherd; Gordon L Phillips
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1224-32.